Prot#D3255C00001: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Use of Benralizumab for Eosinophilic Esophagitis (MESSINA)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/6/20 → 11/6/24

Funding

  • DrugDev Inc. (Prot#D3255C00001 // Prot#D3255C00001)
  • AstraZeneca Pharmaceuticals LP (Prot#D3255C00001 // Prot#D3255C00001)